Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stem Cell Infusion for Advanced Liver Cirrhosis
NCT01412593Phase 2Unknown
- Sponsor
- King Saud University
- Start
- Sep 2011
- Primary completion
- Sep 2012
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of autologous bone marrow-derived stem cells in Liver cirrhosis (LC) (2 arms), sponsored by King Saud University. Primary endpoint: Model for End-Stage Liver Disease score at 2 years. Status: unknown.
02
Drugs
autologous bone marrow-derived stem cells
03
Conditions
Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT01412593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01412593.